CICC Raises Smoore International Target Price by 47% to HKD 11.5

Business by 2FIRSTS.ai
Jun.20.2024
CICC Raises Smoore International Target Price by 47% to HKD 11.5
Smoore International (06969.HK) Report: E-cigarette sales expected to rise with new businesses flourishing; target price raised by 47%.

On June 19th, CICC released a report titled "Smoore International (06969.HK): Multiple categories of vape products steadily improving, new businesses such as HNB expected to enter harvest period." The report pointed out that with strengthened regulations in Europe and the United States, improving sales of new products, and continued strong overseas demand, the company's e-cigarette products in multiple categories are expected to steadily improve in growth prospects. The company's global market share is expected to increase, and new businesses such as HNB, vaporized beauty, and medical products are also expected to gradually enter a harvest period. CICC maintains a outperform rating on Smoore International, raising the target price by 47% to HKD 11.5.

 

The reasons listed by Zhongjin Company are as follows:

 

  1. With the development of new products and the enhancement of localization operations, the growth potential of multi-category e-cigarettes is expected to steadily improve.

 

  1. Disposable: Overseas markets have maintained a strong demand for disposable terminals, with the promotion of new products to major clients and successful acquisition of new customers. The company's disposable products are expected to continue to grow. 
  2. APV, THC: With strengthened product capabilities, optimized product matrix, and improved local teams and channels overseas, the company's self-owned brand APV is expected to continue growing rapidly, while the growth potential of THC is expected to recover. 
  3. Pod system: The company has long-term strategic partnerships with major clients such as Vuse alto, and supply prices are expected to remain stable. Despite short-term pressure due to high base numbers and disruptions from illegal products, it is expected to stabilize and improve in the second half of 2024.

 

2. Overseas e-cigarette regulations are tightening, benefiting leading companies like Smoore with the potential to increase their market share in the medium to long term.

 

  1. Europe: The UK plans to implement a comprehensive ban on disposable e-cigarettes from April 2025, with restrictions on the sale of non-rechargeable or refillable e-cigarette products. According to the General Administration of Customs, exports of disposable e-cigarettes to the UK from China have seen a significant decline since March, while exports of refillable products have shown faster growth. 
  2. United States: Currently, multiple states in the US have passed legislation requiring registration of e-cigarette products. Each state can refer to the FDA's PMTA review process to determine a whitelist for e-cigarette products within their jurisdiction, and establish regulations for product and distribution channels. This regulatory framework is expected to support compliant e-cigarette brands and contribute to their growth. With overseas regulations strengthening, the share of illegal products and disposable e-cigarettes is expected to decrease, while refillable and APV products are likely to capture some consumer demand. Companies leading in research and development, manufacturing capabilities, and offering a variety of compliant products stand to benefit from regulatory standardization in the long term, as they work with major customers to increase their global market share.

 

3. The new business is expected to enter a period of harvest, with the company seen as a global leader in atomization technology due to its research and development advantages. There is optimism for the future growth prospects of multiple businesses working together. The company believes that its continued investment in research and development will support long-term growth, with an estimated cumulative research and development investment of over 4.5 billion RMB from 2022 to 2024. Subsequently, the new business is expected to see a period of harvest.

 

  1. According to Frost & Sullivan, the global HNB end market is estimated to reach around 19.42 billion US dollars in 2028, with a CAGR of 18% from 2023 to 2028. The company continues to focus on research and development of innovative heating technology, aiming to provide a differentiated user experience. It is expected to successfully collaborate with major overseas clients in the future, becoming a new pillar of growth in the medium to long term. 
  2. The company launched the "Lanzhi" atomized beauty product solution in March, with potential for simultaneous advancement in both the consumer and business sectors. The development of atomized delivery products for treating diseases such as COPD and asthma is progressing smoothly, with the potential for the atomized medical business to gradually enter a period of harvest in the future.

 

Finally, CICC has decided to maintain its profit forecast unchanged, with the current price corresponding to a P/E ratio of 31/26 for 24/25 years. The rating of outperforming the industry is maintained, based on the potential success and broad development prospects of new businesses. The target price has been raised by 47% to HK$11.5, corresponding to a P/E ratio of 41/34 for 24/25 years, with a 20% upside potential.


Related Reading:

 

CICC: Initiates coverage on Smoore International with a target price of HK$51.5, rating it as "outperform" in the industry.

 

In August 2020, China International Capital Corporation awarded Smoore International (06969) a target price of HK$51.5 and a rating of "outperform industry". The company was described as being in a favorable position within the current tobacco industry. China International Capital Corporation predicted that with the advancement of the US PMTA, and clearer global regulatory policies, the company's market share is expected to further concentrate towards leading companies. Future expansion of new customers, extension into new sectors, and mergers and acquisitions are expected to become important growth points for the company.

 

Smoore's technology brand FEELM is making a comprehensive debut of its innovative solutions in Dubai.

 

FEELM made a comprehensive debut at the e-cigarette exhibition in Dubai (DWTC) with 10 long-awaited innovative solutions. Targeting the pain points of different market consumers, these solutions either break through individually or come together to bring a complete upgrade to the product experience through technological innovation.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
A new Swedish study found oral mucosal lesions in 79% of examined nicotine pouch users and 89% of tobacco-derived snus users, with different tissue-response patterns between the two categories. For manufacturers and regulators, the findings shift attention toward product formulation, flavouring, pouch materials and local oral exposure, not only whether a product contains tobacco. The study found no higher prevalence of caries or periodontal disease, but it could not establish causality, long-term outcomes or differences between individual products or designs.
Special Report
Jul.27
WIRED Investigation: Chinese-Made Vapes Turn to 6-Methyl-Nicotine and Other Analogs, Challenging U.S. Regulation
WIRED Investigation: Chinese-Made Vapes Turn to 6-Methyl-Nicotine and Other Analogs, Challenging U.S. Regulation
U.S. technology and investigative publication WIRED has examined how nicotine analogs are emerging as a new challenge for the country’s vape regulatory framework. The article argues that after the U.S. expanded federal oversight of nicotine products in 2022, some manufacturers began using nicotine-like compounds such as 6-methyl-nicotine that may fall outside existing definitions. Researchers cited by WIRED said some nicotine analogs could be more potent than traditional nicotine, although human health impacts remain unclear. U.S. policymakers are considering broader definitions of nicotine to bring these compounds under federal oversight.
Jul.27
2Firsts Hosts U.S. Market Mid-Year Briefing: Companies Need to Reassess Product and Market-Access Strategies
2Firsts Hosts U.S. Market Mid-Year Briefing: Companies Need to Reassess Product and Market-Access Strategies
2Firsts held its 2026 U.S. Market Compliance and Development Mid-Year Briefing in Shenzhen, China, on July 28. The discussion examined how state-level requirements, proposed foreign-establishment registration rules and expanding supply-chain responsibilities are changing product and investment decisions in the U.S. tobacco and nicotine market.
Jul.29
Special Report|AIR H1 Revenue Rises 3.7% as Shisha Volumes Fall 9%, Testing Its Shift Beyond Traditional Hookah
Special Report|AIR H1 Revenue Rises 3.7% as Shisha Volumes Fall 9%, Testing Its Shift Beyond Traditional Hookah
AIR’s first half-year results as a listed company offer a new test of how far a traditional hookah business can transform. H1 2026 revenue rose 3.7%, even as Flavored Shisha Molasses shipments fell 9%, with pricing and mix supporting growth. Traditional shisha still generates almost all revenue, while OOKA, Crown Switch, Greentank and U.S. regulatory spending point to accelerating diversification. The next test is whether those investments can become a second business of meaningful scale and profitability.
Capital Markets
Aug.21
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
A new expert paper in JAMA urges U.S. clinicians to include nicotine e-cigarettes in smoking-cessation discussions, citing higher quit rates than nicotine replacement therapy. It also stresses that products must deliver enough nicotine to replace cigarettes, dual use should be brief, and complete switching is the goal. 2Firsts argues the recommendations matter beyond clinics: public-health professionals should reassess relative risk, regulators should preserve sufficient product appeal for adult smokers, and manufacturers should focus on helping users quit cigarettes more sustainably.
SCIENCE
Aug.03 by 2Firsts Perspectives
French Anti-Tobacco Group Questions PMI’s IQOS “Curiosity” Campaign Over Potential Youth Appeal
French Anti-Tobacco Group Questions PMI’s IQOS “Curiosity” Campaign Over Potential Youth Appeal
According to French anti-tobacco group Générations Sans Tabac, Philip Morris International’s (PMI) IQOS “Curiosity” campaign has drawn attention from public health advocates. The group argues that the campaign uses themes including curiosity, exploration and lifestyle branding that could increase interest among younger audiences. PMI has positioned IQOS as a key part of its smoke-free product strategy, while France maintains strict restrictions on tobacco and nicotine product marketing. The debate highlights ongoing tensions between heated tobacco branding strategies and public health concerns in Europe.
Jul.24